top of page

Bay Area based Ridge Bio is using machine learning in the wet lab at large scale, but with a cell free platform, to develop optimized linkers for antibody-drug conjugates and precision enzymes

  • 3 hours ago
  • 1 min read

Co-Founder & CEO Weston Kightlinger describes the advantages of only using a cell's internal machinery rather than the entire cell in their experiments at scale, and how they are using this to help other companies develop more precisely engineered drug candidates.



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

HSBC_IB_Stacked_logo.png

HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.

​

​Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.

Learn more

bottom of page